Strategies for active and passive pediatric RSV immunization

Strategies for active and passive pediatric RSV immunization

Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children worldwide, with the most severe disease occurring in very young infants. Despite half a century of research there still are no licensed RSV vaccines. Difficulties in RSV vaccine development stem...

Full description

Bibliographic Details
Main Authors:	Katherine M. Eichinger, Jessica L. Kosanovich, Madeline Lipp, Kerry M. Empey, Nikolai Petrovsky
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-02-01
Series:	Therapeutic Advances in Vaccines and Immunotherapy
Online Access:	https://doi.org/10.1177/2515135520981516

Similar Items

Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection
by: Katherine M. Eichinger, et al.
Published: (2020-07-01)

Data describing IFNγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (RSV)
by: Katherine M. Eichinger, et al.
Published: (2017-10-01)

Immunity to RSV in Early Life
by: Laura eLambert, et al.
Published: (2014-09-01)

NEONATAL IMMUNE MODULATION TO IMPROVE PNEUMOCYSTIS CLEARANCE
by: Empey, Kerry McGarr
Published: (2007)

Endocannabinoid engagement of CB2 regulates RSV-induced immunity
by: Barbara L. F. Kaplan
Published: (2018-12-01)

Regulation of immune responses and viral persistence in RSV infection
by: Lee, Debbie Ching Ping
Published: (2009)

Global molecular diversity of RSV – the “INFORM RSV” study
by: Annefleur C. Langedijk, et al.
Published: (2020-06-01)

Respiratory Syncytial Virus (RSV) Induces Innate Immunity through Toll-Like Receptors and Acquired Immunity via the RSV G Protein: A Dissertation
by: Murawski, Matthew R.
Published: (2009)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
by: Anne M Hause, et al.
Published: (2017-01-01)

Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.
by: Gertrud U Rey, et al.
Published: (2013-01-01)

Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity
by: Erica Stewart, et al.
Published: (2019-08-01)

The effect of temperature on the innate immune response in the lungs against RSV
by: Chrifi, Wail
Published: (2020)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
by: Anne M Hause, et al.
Published: (2017-01-01)

Current Insights Into Host Immune Responses to Human Respiratory Syncytial Virus (RSV) and Challenges Towards Efficient Treatments and Vaccines Against RSV
Published: (2020)

Monitoring Severity of Respiratory Syncytial Virus (RSV) in Infants and Young Children Using the Pediatric RSV Electronic Severity and Outcome Rating System (PRESORS): Results of Initial Quantitative Validation
by: de la Loge C, et al.
Published: (2021-07-01)

In vitro model for the assessment of human immune responses to subunit RSV vaccines.
by: Tatiana Chirkova, et al.
Published: (2020-01-01)

RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization
by: Sarah Wilmschen, et al.
Published: (2019-07-01)

Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
by: Catalina A. Andrade, et al.
Published: (2020-06-01)

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.
by: H K Brand, et al.
Published: (2015-01-01)

Temperature-sensitive mutants of Rous sarcoma virus (RSV) : isolation and use in the study of RSV replication and recombination
by: Pettigrew, M. W.
Published: (1979)

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
by: Rachel J Derscheid, et al.
Published: (2013-01-01)

Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
by: Yvette N. Löwensteyn, et al.
Published: (2021-08-01)

Local variations in the timing of RSV epidemics
by: Douglas B. Noveroske, et al.
Published: (2016-11-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
by: Selir M. Straliotto, et al.
Published: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
by: Selir M. Straliotto, et al.
Published: (1994-03-01)

Analysis of Human RSV Immunity at the Molecular Level: Learning from the Past and Present.
by: Kerrie Vaughan, et al.
Published: (2015-01-01)

Correction to: Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol
by: Yvette N. Löwensteyn, et al.
Published: (2021-09-01)

Bronchiolitis: Comparative Study between Respiratory Synctial Virus (RSV) and Non RSV Aetiology
by: Anirban Mandal, et al.
Published: (2017-02-01)

Emergency Department Septic Screening in Respiratory Syncytial Virus (RSV) and Non-RSV Bronchiolitis
by: Chee, Chris, et al.
Published: (2010-02-01)

Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV
by: Maaike Nederend, et al.
Published: (2020-08-01)

Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of Age.
by: Jop Jans, et al.
Published: (2017-01-01)

Nasal Microbiota in RSV Bronchiolitis
by: Serena Schippa, et al.
Published: (2020-05-01)

Cleavage-preventing mutations in the RSV G protein and their effects on vaccine infectivity and immune response
by: Jenkins, Tiffany
Published: (2020)

Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection
by: Dorothea Morris, et al.
Published: (2019-08-01)

Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein
by: Lori M. Cullen, et al.
Published: (2019-02-01)

Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine
by: Krause Anja, et al.
Published: (2011-07-01)

Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, Canada
by: Shokoofeh Nourbakhsh, et al.
Published: (2021-11-01)

Evaluating the next generation of RSV intervention strategies: a mathematical modelling study and cost-effectiveness analysis
by: David Hodgson, et al.
Published: (2020-11-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
by: Ralph A. Tripp, et al.
Published: (2020-07-01)

The Contribution of Neutrophils to the Pathogenesis of RSV Bronchiolitis
by: Ismail Sebina, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_1nghi3rkofjn7o1jjhnj27ehu6